An evidence-based guide to SARS-CoV-2 vaccination of patients on immunotherapies in dermatology

Immune-mediated diseases and immunotherapeutics can negatively affect normal immune functioning and, consequently, vaccine safety and response. The COVID-19 pandemic has incited research aimed at developing a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. As SARS-CoV-2 v...

Descripción completa

Detalles Bibliográficos
Autores principales: Gresham, Louise M., Marzario, Barbara, Dutz, Jan, Kirchhof, Mark G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816618/
https://www.ncbi.nlm.nih.gov/pubmed/33482251
http://dx.doi.org/10.1016/j.jaad.2021.01.047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816618/
https://www.ncbi.nlm.nih.gov/pubmed/33482251
http://dx.doi.org/10.1016/j.jaad.2021.01.047

Ejemplares similares